These data indicate that increased Rgl2 expression does not affect ß-AR-induced increases in cardiac mass; however, Rgl2 expression protects from ß-AR-induced cardiomyocyte injury, apoptosis, and increased cardiac fibrosis. The gene discussed is RGL2; the disease is fibrosis.